Taken together, these results indicate that downregulation of PAR1 activates the Hippo pathway and thus inhibits the expression of YAP/TAZ, leading to a decrease of Foxc2 and suppression of EMT in breast cancer cells. This evidence concerns the gene F2R and breast cancer.